9,979 Shares in Invesco Nasdaq Biotechnology ETF $IBBQ Acquired by Atria Investments Inc

Atria Investments Inc purchased a new position in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 9,979 shares of the company’s stock, valued at approximately $211,000. Atria Investments Inc owned approximately 0.66% of Invesco Nasdaq Biotechnology ETF as of its most recent SEC filing.

Separately, CreativeOne Wealth LLC purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 1st quarter worth $222,000.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ:IBBQ opened at $27.53 on Friday. The firm has a market capitalization of $45.70 million, a PE ratio of 17.03 and a beta of 0.67. The business’s fifty day moving average price is $25.28 and its 200 day moving average price is $22.96. Invesco Nasdaq Biotechnology ETF has a 12 month low of $17.84 and a 12 month high of $27.78.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Stockholders of record on Monday, September 22nd were given a dividend of $0.0958 per share. The ex-dividend date of this dividend was Monday, September 22nd. This represents a $0.38 annualized dividend and a dividend yield of 1.4%. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.03.

Invesco Nasdaq Biotechnology ETF Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.